Caring for Cancer Survivors: a Survey of Primary Care Physicians
Overview
Authors
Affiliations
Background: The number of long-term US cancer survivors is expected to double by the year 2050. Although primary care physicians (PCPs) provide the majority of care for long-term cancer survivors, to the authors' knowledge, few data to date have detailed PCP practice patterns, attitudes, and challenges in caring for long-term cancer survivors.
Methods: Self-administered surveys were mailed to 406 community- and academic-based general internal medicine physicians in Denver, Colorado. Survey development included in-depth physician interviews and pretesting. Of the 299 responses, 72 were ineligible; an analysis of the data from 227 surveys is presented.
Results: The response rate was 76%. Community-based PCPs comprised 70% of completed surveys. Reported care patterns were assessed to create a multidimensional care score reflecting levels of attention to 4 areas of survivorship care: monitoring for cancer recurrence, management of late effects, sexual functioning, and mental health. Only 24% of PCPs met criteria for routinely providing more multidimensional survivorship care. More recent medical school graduates reported providing less multidimensional survivorship care when compared with their more experienced colleagues. Approximately 82% of PCPs believed that primary care guidelines for adult cancer survivors are not well defined, and 47% of PCPs cited inadequate preparation and lack of formal training in cancer survivorship as a problem when delivering care to long-term survivors.
Conclusions: Although PCPs provide the bulk of care for long-term survivors within the survivorship phase of the cancer trajectory, only a small subset have reported providing multidimensional survivorship care. Results underscore a need for substantially increased training in survivorship care to support the delivery of multidimensional primary care for long-term survivors.
Lax H, Baum J, Lehmann N, Merkel-Jens A, Beelen D, Jockel K Cancer Med. 2024; 13(7):e7095.
PMID: 38549460 PMC: 10979186. DOI: 10.1002/cam4.7095.
Kluczynski M, Rodriguez E, McGillicuddy C, Schlecht N Vaccines (Basel). 2024; 12(2).
PMID: 38400098 PMC: 10892003. DOI: 10.3390/vaccines12020114.
COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors.
Park J, Koo H, Lee J, Lee H, Lee J J Korean Med Sci. 2024; 39(2):e6.
PMID: 38225782 PMC: 10789529. DOI: 10.3346/jkms.2024.39.e6.
Devi G, Fish L, Bennion A, Sawin G, Weaver S, Reddy K Prev Med Rep. 2023; 36:102519.
PMID: 38116289 PMC: 10728446. DOI: 10.1016/j.pmedr.2023.102519.
Myths and Presumptions About Cancer Survivorship.
Halpern M, Mollica M, Han P, Tonorezos E J Clin Oncol. 2023; 42(2):134-139.
PMID: 37972343 PMC: 10824378. DOI: 10.1200/JCO.23.00631.